Patient Barriers to Mammography Identified During a Reminder Program
- PMID: 21275649
- PMCID: PMC3117308
- DOI: 10.1089/jwh.2010.2195
Patient Barriers to Mammography Identified During a Reminder Program
Abstract
Background: Patient mammogram reminders are effective at increasing screening, but patient barriers remain. We evaluated patient characteristics and reported barriers for their association with mammogram completion after a reminder program. Methods: This retrospective cohort study used data from electronic records and a subgroup survey. Participants were female Kaiser Permanente Northwest health maintenance organization (HMO) members aged 50-69 who were 20 months past their last mammogram (index date) and had received a reminder intervention (n = 4708). A mailed survey was completed by 340 of 667 (50.2%) women who received it. The intervention was a "mammogram due soon" postcard 20 months after the last mammogram, followed by up to two automated phone calls and one live call for nonresponders. The outcome was mammogram completion at 10 months after index date. Results: Characteristics associated with lower mammogram completion rates were aged <60 (odds ratio [OR] 0.69, p < 0.0001), health plan membership <5 years (OR 0.81, p = 0.019), family income <$40,000/year (OR 0.77, p = 0.018), and obesity (OR 0.67, p < 0.0001). Obese women were more likely than nonobese women to report "too much pain" from mammograms (31.3% vs.18.8%, p < 0.01). Younger women were more likely to endorse that they were "too busy" (19.1% vs. 6.4%, p < 0.001) and had more worries about mammogram accuracy (2.5 vs. 2.3 on a 5-point scale, p < 0.05). Pain mediated the relationship between obesity and mammogram completion rates (indirect effect = -0.111, p = 0.008). Conclusions: Important barriers to mammogram completion remain even after an effective mammogram reminder system among insured patients. Tailored interventions are necessary to overcome these barriers.
Figures
Similar articles
-
Effect of a multimodal reminder program on repeat mammogram screening.Am J Prev Med. 2009 Aug;37(2):94-101. doi: 10.1016/j.amepre.2009.03.022. Am J Prev Med. 2009. PMID: 19589447 Free PMC article.
-
Implementation and process evaluation of three interventions to promote screening mammograms delivered for 4 years in a large primary care population.Transl Behav Med. 2017 Sep;7(3):547-556. doi: 10.1007/s13142-017-0497-x. Transl Behav Med. 2017. PMID: 28452044 Free PMC article. Clinical Trial.
-
Study of socio-economic characteristics, diagnosis and outcome of women participating or not participating in mammogram screening.Ann Ig. 2014 Nov-Dec;26(6):518-26. doi: 10.7416/ai.2014.2010. Ann Ig. 2014. PMID: 25524076
-
The effect of patient and provider reminders on mammography and Papanicolaou smear screening in a large health maintenance organization.Arch Intern Med. 1997 Aug 11-25;157(15):1658-64. Arch Intern Med. 1997. PMID: 9250226 Clinical Trial.
-
Reminder systems to improve patient adherence to tuberculosis clinic appointments for diagnosis and treatment.Cochrane Database Syst Rev. 2014 Nov 18;2014(11):CD006594. doi: 10.1002/14651858.CD006594.pub3. Cochrane Database Syst Rev. 2014. PMID: 25403701 Free PMC article. Review.
Cited by
-
Facilitators and Barriers to Lung Cancer Screening during Long COVID: A Global Systematic Review and Meta-Study Synthesis of Qualitative Research.Int J Environ Res Public Health. 2024 Apr 25;21(5):534. doi: 10.3390/ijerph21050534. Int J Environ Res Public Health. 2024. PMID: 38791759 Free PMC article. Review.
-
Understanding patient barriers and facilitators to uptake of lung screening using low dose computed tomography: a mixed methods scoping review of the current literature.Respir Res. 2022 Dec 23;23(1):374. doi: 10.1186/s12931-022-02255-8. Respir Res. 2022. PMID: 36564817 Free PMC article. Review.
-
Breast cancer detection by analyzing the volatile organic compound (VOC) signature in human urine.Sci Rep. 2022 Sep 1;12(1):14873. doi: 10.1038/s41598-022-17795-8. Sci Rep. 2022. PMID: 36050339 Free PMC article.
-
Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia.Int J Womens Health. 2022 Mar 12;14:373-384. doi: 10.2147/IJWH.S343558. eCollection 2022. Int J Womens Health. 2022. PMID: 35309953 Free PMC article.
-
Identify factors for insufficient (> 2 yr) mammogram screening among Oregonian women.Cancer Causes Control. 2022 Feb;33(2):293-301. doi: 10.1007/s10552-021-01529-8. Epub 2022 Jan 7. Cancer Causes Control. 2022. PMID: 34993663 Free PMC article.
References
-
- Berry DA. Cronin KA. Plevritis SK, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005;353:1784–1792. - PubMed
-
- Overmoyer B. Breast cancer screening. Med Clin North Am. 1999;83:1443–1557. - PubMed
-
- National Cancer Institute. Surveillance Epidemiology and End Results. seer.cancer.gov/statfacts/html/breast.html. seer.cancer.gov/statfacts/html/breast.html
-
- U.S. Preventive Services Task Force. Screening for breast cancer, Topic page. AHRQ, 2009. www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm. www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm
-
- Valanis BG. Glasgow RE. Mullooly J, et al. Screening HMO women overdue for both mammograms and Pap tests. Prev Med. 2002;34:40–50. - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous
